The effect of mesalazine for chemoprevention in early grade dysplasia in ulcerative colitis

Authors :: Ullman, T.A.
Croog, V.
Kornbluth, A.
Harpaz, N.
Itzkowitz, S.H.
Source :: Gut. April 2004, Vol. 53 Issue 4, , A119, p2 p.
Publication Year :: 2004
Abstract: Background: Some studies suggest that mesalazine (5-ASA) can attenuate the rate of progression of ulcerative colitis (UC) to colorectal cancer (CRC). Little is known about where in the colitis-dysplasiacarcinoma sequence [...]

Subjects :: Ulcerative colitis -- Care and treatment -- Research
Mesalamine -- Health aspects -- Research
Colorectal cancer -- Care and treatment -- Research
Chemoprevention -- Health aspects -- Research
Health
Care and treatment
Research
Health aspects

Tools